Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.
Ryan David NippHang LeeEmily GortonMorgan LichtensteinSalome KuchukhidzeElyse ParkBruce A ChabnerBeverly MoyPublished in: The oncologist (2019)
Clinical trials are critical for developing novel therapies for patients with cancer, yet financial barriers may discourage some patients from participating in cancer clinical trials. This study found that patients who received financial assistance from an equity intervention experienced significant improvements over time in their concerns about the cost of travel and lodging associated with clinical trials compared with comparison patients who did not receive financial assistance from the equity intervention. Among cancer clinical trial participants, an equity intervention shows potential for addressing patients' concerns regarding clinical trial-related travel and lodging expenses.
Keyphrases
- clinical trial
- randomized controlled trial
- end stage renal disease
- phase ii
- papillary thyroid
- open label
- chronic kidney disease
- ejection fraction
- childhood cancer
- newly diagnosed
- squamous cell
- double blind
- phase iii
- study protocol
- peritoneal dialysis
- prognostic factors
- healthcare
- squamous cell carcinoma
- physical activity
- patient reported outcomes
- risk factors